With shares of Adobe�(NASDAQ:ADBE) trading around $54, is ADBE an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s MovementAdobe operates as a diversified software company worldwide. It offers a line of software and services used by creative professionals, marketers, knowledge workers, application developers, enterprises, and consumers. Adobe markets and licenses its software directly to enterprise customers through its sales force and to end-users through application stores and its website. Software products and platforms are seeing an increased adoption rate worldwide by consumers and businesses who are seeing increased technology exposure. The efficiency and ease offered by Adobe products make it a viable option to many.
Adobe�� recent security breach is looking much worse than what was reported last month. According to the Sophos Naked Security blog, information on 150 million Adobe customers has turned up on a website frequently used by hackers and other cyber criminals. The blog said this could end up being one of the worst security breaches in online history, according to The Verge. Adobe stands by the 38 million figure that it gave last month, while Sophos is accusing the company of inadequately encrypting its data.
Best Tech Stocks To Own Right Now: BioTime Inc (BTX)
BioTime, Inc., incorporated on November 30, 1990, is a biotechnology company focused on the emerging field of regenerative medicine. Its commercial strategy is focused on its line of research products, such as ACTCellerate cell lines and associated ESpan culture media, HyStem hydrogels, human embryonic stem (hES) cell lines, and royalties from Hextend. Its focus is to provide regenerative therapies for age-related degenerative diseases. In January 2011, the Company acquired the assets of Cell Targeting, Inc. (CTI), a biotechnology company focused on methods of painting molecules on the surface of cells, which in turn causes the cells to adhere to particular tissues, such as those afflicted with disease. On March 21, 2011, the Company acquired Glycosan BioSystems, Inc. (Glycosan) through a merger of Glycosan with OrthoCyte Corporation (OrthoCyte). Through the merger, OrthoCyte acquired all of Glycosan�� assets, including Glycosan�� Hystem hydrogel product line. In March 2011, the Company entered into an agreement with XenneX, Inc., pursuant to which it organized LifeMap Sciences, Inc. (LifeMap), a subsidiary formed to advance the development and commercialization of its human embryonic stem (hES) cell data base. In August 2011, four hES cell lines (ESI-035, ESI-049, ESI-051 and ESI-053) developed by its subsidiary ES Cell International (ESI) were approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry. In May 2012, the Company acquired XenneX, Inc., through a merger of XenneX into LifeMap Sciences. In September 2012, the Company formed a wholly owned subsidiary, BioTime Acquisition Corporation. In October 2013, Geron Corporation announced the closing of the transaction to divest the Company's stem cell assets to Asterias Biotherapeutics, Inc., a subsidiary of BioTime, Inc.
HyStem is a biomaterial, which mimics the human extracellular matrix, which is the network of molecules surrounding cells in organs and tissues which is essent! ial to cellular function. Its HyStem hydrogels may have other applications when combined with the diverse and scalable cell types its scientists have isolated from hES cells. HyStem-Rx is a clinical grade formulation of HyStem-C, a biocompatible, implantable hyaluronan and collagen-based matrix for cell delivery in human clinical applications. Its subsidiary, OncoCyte Corporation, is developing PanC-Dx, a non-invasive blood-based cancer screening test designed to detect the presence of various human cancers, including cancers of the breast, lung, bladder, uterus, stomach, and colon, during routine check -ups. BioTime Asia, Limited (BioTime Asia) sells products for research use and may develop therapies to treat cancer and neurological and orthopedic diseases in Asia. OrthoCyte Corporation (OrthoCyte) is developing therapies to treat orthopedic disorders, diseases and injuries. ReCyte Therapeutics, Inc. (ReCyte Therapeutics) is developing therapies for age-related cardiovascular and blood disorders. Cell Cure Neurosciences Ltd. (Cell Cure Neurosciences), is a biotechnology company focused on developing stem cell-based therapies for retinal and other neurological disorders, including the development of retinal pigment epithelial (RPE) cells for the treatment of age-related macular degeneration. LifeMap Sciences, Inc. (LifeMap) is advancing the development and commercialization of our embryonic stem cell database and plans to make the database available for the marketing of research products and for use by stem cell researchers at pharmaceutical and biotechnology companies and other institutions via paid subscriptions or on a fee per use basis.
The Company�� blood plasma expander product, Hextend, is a physiologically balanced intravenous solution used in the treatment of hypovolemia, a condition caused by low blood volume, often from blood loss during surgery or injury. Hextend maintains circulatory system fluid volume and blood pressure, and keeps vital organs perfused during surgery and t! rauma car! e. Hextend is manufactured and distributed in the United States by Hospira, Inc., and in South Korea by CJ CheilJedang (CJ), under license from it.
Human Embryonic Stem Cell Lines for Research Use
Combined with the Company�� ACTCellerate technology, it derives of a range of markets human embryonic progenitor cells (hEPCs). ESI�� six current good manufacturing practices (cGMP) hES cell lines have been approved by the NIH for inclusion in the Human Embryonic Stem Cell Registry, which renders those cell lines eligible for use in federally funded research. The ESI hES cell lines are available for purchase through www.biotimeinc.com. It also markets hEPCs developed using ACTCellerate technology. Its hEPCs are also available for sale through www.biotimeinc.com. It derived the complete genome sequence of five of the ESI hES cell lines to facilitate the development of products derived from these cell lines. It has made these GMP-grade cell lines, along with certain documentation and complete genomic deoxyribonucleic acid (DNA) sequence information, available for sale.
The Company offers human stem cell products and technology that can be used by researchers at universities and at companies in the bioscience and biopharmaceutical industries. It has developed research and clinical grade hES cell lines, which it markets for both basic research and therapeutic product development. It also markets human embryonic progenitor cell (hEPCs) developed using ACTCellerate technology. These hEPCs are purified lineages of cells, which are intermediate in the developmental process between embryonic stem cells and fully differentiated cells. The ACTCellerate cell lines are also available for purchase through http://www.biotimeinc.com.
Human Embryonic Progenitor Cells
Through the Company�� subsidiary ReCyte Therapeutics, it had a license from Advanced Cell Technology, Inc. (ACT) to use ACTCellerate technology, and the rights to market more than 200 human c! ell types! made using that process. ACTCellerate allows the rapid isolation of hEPCs, which are cells that are intermediate in the developmental process between embryonic stem cells and fully differentiated cells.
Through an agreement with ReCyte Therapeutics, Millipore Corporation became a global distributor of ACTCellerate hEPC lines. In addition to the products, which it is co-marketing with Millipore, it offers 92 other ACTCellerate hEPC lines for purchase at www.biotimeinc.com. Through its subsidiary LifeMap, it provides online biomedical database services to increase awareness of molecular markers and diverse cell types comprising its ACTCellerate hEPC lines. It also focuses to market additional cell types manufactured with its PureStem technology. PureStem cell lines are produced by the exogenous expression of specific transcription factors, which regulate the differentiation of cell types from hES or induced pluripotent stem (iPS) cells. BioTime Asia has an agreement with Shanghai Genext Medical Technology Co., Ltd. to sell ACTCellerate hEPC lines and related ESpan growth media to the medical and biological research communities in China, Taiwan, Hong Kong, and Macau on an exclusive basis. The marketing agreement includes provisions for an initial stocking inventory and annual milestones to maintain exclusivity. The Company�� California Institute of Regenerative Medicine (CIRM)-funded research addresses the need for industrial scale production of purified therapeutic cells.
hES Cells Carrying Genetic Diseases
The Company focuses to add to its product line muscle progenitor cells produced from five hES cell lines carrying genes for Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, spinal muscular atrophy Type I, facioscapulohumeral muscular dystrophy 1A, and Becker muscular dystrophy. It obtained the diseased hES cell lines from Reproductive Genetics Institute (RGI).
ESpan Cell Growth Media
The Company is marketing a range of! cell-gro! wth media products called ESpan. These growth media are optimized for the growth of hEPC types. Cells need to be propagated in liquid media, in both the laboratory setting, where basic research on stem cells is performed, and in the commercial sector. Its ESpan products are marketed through Millipore and Genext.
ESpy Cell Lines
The Company focuses for development of ESpy cell lines. The ability of the ESpy cells to emit light will allow researchers to track the location and distribution of the cells in both in vitro and in vivo studies.
HyStem Hydrogel for Research and HyStem-Rx for Cell Delivery Medical Devices
HyStem is a patented biomaterial that mimics the ECM, the network of molecules surrounding cells in organs and tissues that is essential to cellular function. Its HyStem technology forms the foundation for stem cell delivery products in both the adult and embryonic stem cell marketplace, including products manufactured using its ACTCellerate technology. As an injectable product, HyStem-Rx may address need in cosmetic and reconstructive surgeries and other procedures by transplanting adipose derived cells or other adult stem cells. The transfer of cells in HyStem-Rx localizes the transplanted cells at the intended site and by providing a three-dimensional scaffold upon which cells can rebuild normal tissue. HyStem-Rx may support other emerging cell and tissue transplant therapies, such as those derived from hES and iPS cells, in addition to its potential application in the treatment of a range of conditions such as osteoarthritis, brain tumors, stroke, bone fracture, and wounds.
Advisors' Opinion:- [By John Udovich]
Stem cell stocks have not exactly been the best performers lately in part because the controversy over their use has died down over the years while major breakthroughs have been few or far between, but the industry along with small cap stem cell stocks Pluristem Therapeutics Inc (NASDAQ: PSTI), BioTime, Inc (NYSEMKT: BTX) and BioRestorative Therapies (OTCBB: BRTX) are still quietly producing their share of news or minor breakthroughs worth taking note of. Just consider the following stem cell news or news from small cap players in the sector:
- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biotechnology company BioTime (NYSEMKT: BTX ) has received the dreaded one-star ranking.
Best Tech Stocks To Own Right Now: Agios Pharmaceuticals Inc (AGIO)
Agios Pharmaceuticals, Inc., incorporated on August 7, 2007, is a biopharmaceutical company. The Company is intend to apply its deep understanding of metabolism, coupled with the Company�� ability to create medicines that can inhibit or activate metabolic enzymes, to fundamentally change the way cancer and inborn errors of metabolism (IEMs) are treated. The Company has identified and validated novel and druggable targets in both cancer and IEMs. The Company�� two advanced cancer programs are targeting mutations in the enzymes isocitrate dehydrogenase 1 and 2, referred to as IDH1 and IDH2. The Company�� drug candidates are selective for the mutated forms of IDH1 and IDH2 found in cancer cells versus the normal forms of IDH1 and IDH2 found in all other cells.
The Company focused on developing medicines to address IEMs, with a novel approach to these orphan diseases for which no effective or disease-modifying therapy is available. The Company has also de-validated and terminated numerous programs, including many that have been reported in scientific journals. In the Company�� IEM portfolio, it uses an equally rigorous set of validation techniques.
Advisors' Opinion:- [By Lisa Levin]
Agios Pharmaceuticals (NASDAQ: AGIO) shares touched a new 52-week low of $18.83. Agios Pharmaceuticals' trailing-twelve-month profit margin is -102.87%.
Top Warren Buffett Stocks To Watch For 2015: Science Applications International Corp (SAIC)
Science Applications International Corporation, formerly SAIC Gemini, Inc., incorporated on February 1, 2013, is a scientific, engineering, and technology applications company. The Company uses its domain knowledge to solve problems in national security, energy and the environment, critical infrastructure, and health. The Company serves customers in the United States Department of Defense, the intelligence community, the United States Department of Homeland Security, other United States Government civil agencies and selected commercial markets. The Company provides services in two segments: government segment and commercial segment. Its government segment provides an array of technical services and solutions, primarily to United States federal, state and local government agencies and foreign governments. Its commercial segment provides technology-driven consulting, systems integration and outsourcing services and solutions in selected commercial markets.
Services
The Company provides systems development, technical and consulting services to federal, state, local law enforcement and criminal justice agencies, further promoting efficiency and effectiveness in preventing and controlling crime through systems, such as CODIS and LEO. The Company safeguards business-critical information, systems, and Websites with information security assessments and public key infrastructure solutions. The Company simplifies access to government goods and services through pre-negotiated federal contract vehicles. It provides government, commercial, and international clients with solutions to complex financial and resource problems. The Company provides geospatial products, services, and solutions for several industries, including agriculture, utility and defense. It provides a comprehensive portfolio of technology and domain specific solutions to its federal, state and local government and commercial health customers.
The Company helps companies to y operate, maintain, and manage wid! ely dispersed assets through consulting, enterprise asset management (EAM), help desk services and network services. The Company supports all phases for drug development: discovery, pre-clinical and clinical development and operations and compliance. It develops technologies, engineer solutions and provide analytical systems for maritime markets. It helps organizations improve product quality, more accurately determine product development or production schedule/cost, and increase productivity. The Company helps National Aeronautics and Space Administration (NASA) and the military, space and intelligence communities transition to faster, better and cheaper business processes through applied research & technology; information systems, and modeling and simulation. The Company offers corporate and individual training services ranging from elearning to training evaluation.
Aviation
The Company supports commercial and government customers with the latest aviation technology products. The Company�� products include Model 3800 Autopilot, FODetect , AeroPlanner, Memory Unit Tactical Air Crew Training System (MUTACTS), and SAIC Mission Planning System (MPS). The Model 3800 Autopilot is designed for installation in high-performance jet and turboprop aircraft but will function well in a range of fixed-wing aircraft. FODetect is an automated system that provides continuous monitoring with high-resolution and high-speed detection of foreign object debris (FOD) on critical aircraft operating areas. AeroPlanner provides a common tactical picture between control and combat systems by accessing parallel data from naval tactical data systems and retransmitting serially into multiple formats. SAIC's MUTACTS provides quick, accurate and post-flight review and analysis of military aircraft training missions. SAIC MPS consists of a line of simple to use computerized aircraft mission planning systems available for aircraft around the world.
Geospatial Products
The Company o! ffers a f! amily of geospatial solutions to support and gather GIS information for defense, intelligence and commercial customers. Its products include AeroPlanner.com, GRGlobe, GeoRover Software Products, ike 504, Percept, and WebCentric Geospatial Collaboration. AeroPlanner.com is a comprehensive flight-planning application for pilots of all levels. The GRGlobe desktop application brings core GIS functionality to a three dimensional (3D) globe environment providing the ability to create, edit, and visualize GIS data natively while supporting multiple formats such, as KML, shapefile and geodatabase. GeoRover geospatial software products are designed and sold as extensions of plug-in to the ArcMap component of Esri ArcGIS software versions 8.x and 9.x. The ike 504 is a handheld, GIS-related device that provides operators with methods to collect geospatial information on a target, including GPS coordinates and a photograph from a position up to 1,000 meters (3,280 feet) away. The SAIC Percept suite connects essential business information with real-world infrastructure and properties data. WebCentric Geospatial Collaboration is a Web-based, commercial-off-the-shelf geospatial presentation tool providing to dimensional (2D), 3D, and four dimensional (4D) views.
Ocean and Marine Systems
The Company develops marine products. These products monitor global climate change and marine meteorology, chart and analyze hydrographic data, and help to manage waste and control pollution. iTs products include COBIA Buoy, SAIC Tsunami Buoy (STB) Systems, ISS-2000, Survey Analysis and area Based EditoR (SABER), Incident Command Tool for Drinking Water Protection (ICWater), Plastics Waste Processor (PWP), Compress Melt Unit (CMU) Mod 0, Compress Melt Unit (CMU) Mod 1: Plastics Waste Processor, Large and Small Pulpers, Large and Small Pulpers, 10 GPM Oily Waste Polishing Unit, Topside and Dockside Chlorinators, and Ship Dechlorinator. COBIA Buoy is designed as a modular and fully reconfigurable buoy platform b! ased on t! echnologically advanced maritime expertise. SAIC Tsunami Buoy (STB) Systems are an enhanced version of the buoy system in use by the National Oceanic and Atmospheric Administration's DART detection system. The ISS-2000 Integrated Survey System was designed for professional hydrographers and surveyors and supports a range of high-performance, shallow-water survey operations. SABER is a tool for processing, editing, updating, viewing and analyzing hydrographic survey data. ICWater is designed to model drinking water contamination in real-time for a rapid, effective emergency response.
Rugged Hardware
The Company�� rugged hardware provides a range of commercial off-the-shelf equipment, as well as specialized custom-designed solutions, for installation into harsh tactical and industrial environments. Its products include Quicklock Cargo Restraint System, Passive LINK Tap (PLT), 1RU 8 Circuit Rugged Power Distribution Assembly (PDA), 1RU Fixed Expansion Chassis, 2RU Rugged cPCI Chassis High-Security Firewall System, Rugged Large liquid-crystal display (LCD) Color Flat Panel Displays (FPDs), Rugged Small LCD FPDs, Neptune 2 Rack Unit Workstation Consoles, and Rugged TigerShark Workstation Consoles. PLT provides a common tactical picture between control and combat systems by accessing parallel data from naval tactical data systems and retransmitting serially into multiple formats. The Quicklock Cargo Restraint System allows for secure tie-down of almost any cargo shape and is designed to prevent damage to and loss of equipment while in transit.
Safety and Security
The Company offers a variety of products to enhance safety and security in transportation, military, emergency response and other applications. Its product includes VACIS Cargo and Vehicle Inspection Systems, VACIS IP6500 FullScan Integrated Inspection System, VACIS XPL Passenger Vehicle Scanning System, and All-Terrain VACIS Imaging System. The Company�� VACIS systems scan cargo containers, tru! cks, cars! and other vehicles to help authorities search for weapons, nuclear material, narcotics, undeclared goods and other contraband at cargo terminals, border crossings, military facilities and other checkpoints. The VACIS IP6500 system safely scans occupied trucks and other vehicles of all sizes. The VACIS XPL system safely scans occupied cars and and other light vehicles.
Simulation
The Company provides a range of simulation products using in system engineering, software engineering, component engineering, signal and image processing, and custom system integration. Its products include OLIVE: On-Line Interactive Virtual Environment, RADSIM Radar Simulation 3.0, Reconfigurable Tactical Operations Simulator (RTOS), Non-Rated Crew Member Manned Module (NCM3), RC-12X Cockpit Procedural Trainer (CPT), Common Driver Trainer (CDT) Product Line, Combat Training Center-Instrumentation Systems (CTC-IS), STK/Missile Modeling Tools (STK/MMT), Tactical Engagement Simulation (TES) Systems, Common Vehicle System (CVS) Kit, CVS Abrams Adapter Kit, CVS Bradley Adapter Kit, Wireless Independent Target System (WITS), MK-19 Simulator Player Unit, Wireless Individual Weapon System (W-IWS), Mini MILES, Air Defense Weapons Systems (ADWS) MILES Kits, and Aviation Tactical Engagement Simulation System (AV-TESS). The Aviation Tactical Engagement Simulation System (AV-TESS) provides a flexible, training solution, tracking and weapons simulation system, and supports live force-on-force and force-on-target training and the evaluation and testing of new air vehicles and weapons systems. The Wireless Independent Target System (WITS) provides noncombat vehicles and targets, such as trucks, bridges and buildings, with a high-fidelity detection system for real-time casualty assessment.
Software
The Company is an SEI Partner for the Capability Maturity Model Integration (CMMI) project, a collaborative effort to provide models for achieving product and process improvement. Its products inc! lude Voic! e Identity Biometric Services (VIBES), Scale2Insight, Secure Multi-Tenancy, Advanced Analytics Suite, TeraText Database System, SIAM, Antfarm, EMTOOLS, MICHELLE, Enterprise Energy Dashboard, GeoRover Software Products, GeoViz- WebCentric GeoSpatial Collaboration, ISS-2000, Survey Analysis and area Based EditoR (SABER), AIMES, ISRCrossCue, RAVE, Omnifluent Suite of Human Language Technology Products, Flexible Tax Manager, SCOPTIMA Supply Chain Software, and Supply Operations Control System (SOCS). The Supply Operations Control System (SOCS) is a personal computer (PC) based inventory management system, and provides asset visibility, inventory control and supply support. SCOPTIMA Supply Chain Software is a secure, Web-enabled inventory system planner that provides demand forecasting to support efficient management and replenishment of large inventories of spare parts for aircraft and other platforms.
Transportation Products
The Company�� transportation systems helps companies and government agencies around the world improve efficiency, enhance safety and security, reduce errors and cut costs. Its products include Integrated Container Information System (ICIS), Intelligent Intermodal Solutions (IIS), Gatestand Driver Kiosk, CraneView Crane-Mounted OCR System, RailView Digital Video Recording System for Locomotives, and Transportation Visibility and Metrics System (TransVM). The RailView system continuously records digital video and key events as the locomotive travels, providing a reliable record for analysis of rail incidents. The CraneView system automatically identifies containers and records stow positions as the containers are moved by quay cranes in real time.
Advisors' Opinion:- [By John Reese]
Indeed, in 2013, the Greenblatt-based portfolio has bounced back strong, returning more than 50%. Below is a look at its current holdings.
EBIX, Inc. (EBIX)
Western Refining (WNR)
DirecTV (DTV)
ITT Educational Services (ESI)
Science Applications International (SAIC)
Weight Watchers International (WTW)
ConocoPhillips (COP)
AmSurg Corp. (AMSG)
PDL BioPharma (PDLI)
AFC Enterprises (AFCE)
Subscribe to Validea here��/p>
- [By alicet236]
Science Applications International Corp (SAIC) Reached the Five-Year Low of $32.20
The prices of Science Applications International Corp (SAIC) shares have declined to close to the five-year low of $32.20, which is 26.3% off the five-year high of $39.88. Science Applications International Corp is owned by one Guru we are tracking. Among them, 1 have added to their positions during the past quarter. Zero reduced their positions. Science Applications International Corp has a market cap of $2.76 billion; its shares were traded at around $32.20 with a P/E ratio of 18.50 and P/S ratio of 0.45. The dividend yield of Science Applications International Corp stocks is 0.87%.
Best Tech Stocks To Own Right Now: Advanced Photonix Inc (API)
Advanced Photonix, Inc. (API), incorporated in June 22, 1988, is engaged in the development and manufacture of optoelectronic devices and value-added sub-systems and systems. The Company serves a variety of global original equipment manufacturers (OEMs) in a variety of industries. API supports its customers from the initial concept and design phase of the product, through testing to full-scale production. API has two manufacturing facilities located in Camarillo, California and Ann Arbor, Michigan. API is a supplier of optoelectronic semiconductors packaged into high-speed optical receivers, custom optoelectronic subsystems and Terahertz instrumentation, serving a variety of global OEM markets. API supports the customer from the initial concept and design of the semiconductor, hybridization of support electronics, packaging and signal conditioning or processing from prototype through full-scale production and validation testing. The target markets served by it are industrial sensing/NDT, military/aerospace, telecom, medical and homeland security. On March 1, 2013, it acquired certain assets of Silonex, Inc.
The Company�� high-speed optical receivers include avalanche photodiode (APD) technology and positive-intrinsic-negative (PIN) photodiode technology based upon III-V materials, including InP, InAlAs, and GaAs. Its optoelectronic subsystems are based on its silicon large area avalanche photodiode (LAAPD), PIN photodiode, FILTRODE detectors and light emitting diode (LED) assemblies. API�� Terahertz sensor product line is targeted at the industrial homeland security and military markets. Using its fiber coupled technology and high speed Terahertz generation and detection sensors, the Company is engaged in transferring Terahertz technology from the laboratory to the factory floor for use in non-destructive testing and real time quality control.
The Company competes with First Sensor, Illinois Tool Works, JDS Uniphase, Neophotonix, U2T and Nippon Electric.
Advisors' Opinion:- [By Bryan Murphy]
When most investors think of optical sensor makers, they tend to think of larger names like Honeywell International Inc.� (NYSE:HON) or Vishay Intertechnology (NYSE:VSH). And well they should. VSH is a $2 billion company, and HON is a $71.5 billion organization. The fact is, however, there are a few small cap stocks in the optical sensor space that are worth a look, and one of them is worth a very close look right now for a very clear reason... Advanced Photonix, Inc. (NYSEMKT:API).
Best Tech Stocks To Own Right Now: Qlik Technologies Inc.(QLIK)
Qlik Technologies Inc. engages in the development, commercialization, and implementation of software products and related services for user-driven business intelligence that enables customers to make business decisions primarily in the Americas, Europe, the Asia-Pacific region, and Africa. It provides QlikView Business Discovery platform, which helps people create and share insights and analysis in groups and across organizations. Business users can explore data, ask and answer their own stream of questions, and follow their own path to insight on their own and in teams and groups. The company also offers maintenance and professional services. It sells its products to a range of industry verticals, including consumer packaged goods, financial services, pharmaceuticals, retail, manufacturing, technology, and healthcare through its direct sales force, as well as through an indirect channel partners comprising distribution partners, value-added resellers, system integrators, and original equipment manufacturers to license and support its software platform. The company was founded in 1993 and is headquartered in Radnor, Pennsylvania.
Advisors' Opinion:- [By Eric Volkman]
Qlik Technologies (NASDAQ: QLIK ) will have a new CFO once July rolls around. The company said that Tim MacCarrick is to take up the post on July 1. He replaces Bill Sorenson, who announced his departure from the firm in February. The two men will temporarily work together to "ensure a smooth transition," according to a company press release announcing the news.
- [By Lee Jackson]
Qlik Technologies Inc. (NASDAQ: QLIK) is a favorite at Baird and was recently upgraded to buy at Jefferies. The company engages in the development, commercialization and implementation of software products and related services for user-driven business intelligence that enables customers to make business decisions primarily in the Americas, Europe, the Asia-Pacific region and Africa. It provides the QlikView Business Discovery platform, which helps people create and share insights and analysis in groups and across organizations. Its strength in business analytics and financial services may bode well after the IBM issues. The Baird price target for the stock is $33, and the consensus number is at $32.27. The stock closed Wednesday at $28.60.
Best Tech Stocks To Own Right Now: Audience Inc (ADNC)
Audience, Inc., incorporated on May 24, 2011, is a provider of voice and audio solutions that improve voice quality and the user experience in mobile devices. The Company�� solutions include hardware-accelerated digital signal processors (DSPs), and audio codecs and associated algorithms for noise suppression in mobile devices. Its computational auditory scene analysis (CASA) maps the sound separation functions in human hearing, into a computational framework. The Company�� platform consists of its DSPs and audio codec, analog and mixed signal circuits and algorithms for voice isolation and noise suppression.
The Company also provides its AuViD graphical design tools to original equipment manufacturers (OEMs). The Company had sold over 250 million processors to its OEM customers as of December 31, 2012. In addition to the mobile device market, the Company�� voice and audio technology is also applicable to a range of other market segments, including automobile infotainment systems, digital cameras, digital televisions, headsets and set top boxes.
The Company�� product portfolio supports both analog and digital interfaces. As of December 31, 2012, the Company offered eS515, eS325, eS305, eS310, eS110, A1028 and A1026 custom voice and audio processors for device platforms, including smartphones, feature phones and media tablets. eS515 is a third generation voice and audio processor with an integrated audio codec, featuring support of three-microphones; eS325is a third generation voice and audio processor that features simultaneous three microphone processing; eS305 is a second generation voice and audio processor utilizing new hardware acceleration architecture and algorithms for far-field, wideband communications and capable of advanced speech recognition assist, and uses an all digital interface; eS310, provides similar capabilities to the eS305; eS110 is a first generation narrowband voice processor designed for real-time communications and far-field as well as near-field u! se with features such as acoustic echo cancelation, voice equalization and automatic gain control; A1026, is a first generation narrowband voice processor designed for real-time communications and typical near-field use, and A1028, which is a first generation narrowband voice processor designed for real-time communications and far-field, as well as near-field use.
The Company derives its revenue primarily from the sale of voice and audio processors to OEMs, which incorporate them into mobile devices. As of December 31, 2012, OEMs, CMs and distributors worldwide had purchased more than 250 million of its processors and incorporated them in over 140 mobile device models.
The Company competes with Maxim, ON Semiconductor, Qualcomm, Texas Instruments Incorporated, Wolfson Microelectronics plc, DSP Group, Inc. and Yamaha Corporation.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Audience (Nasdaq: ADNC ) , whose recent revenue and earnings are plotted below.
Best Tech Stocks To Own Right Now: Biodel Inc (BIOD)
Biodel Inc. (Biodel), incorporated on December 3, 2003, is a development-stage speciality biopharmaceutical company focused on the development and commercialization of treatments for diabetes. The Company develops its product candidates by applying its formulation technologies to existing drugs. Its advanced program involves developing formulations of injectable recombinant human insulin (RHI). In addition to its ultra-rapid-acting insulin formulations, the Company has developed prototype formulations of a liquid glucagon, a basal insulin and a glucose responsive insulin, in each case for use by patients with diabetes. RHI-based formulation known as Linjeta was the subject of a New Drug Application (NDA).
The Company has two pivotal Phase III clinical trials with its preferred commercial formulation of Linjeta prior to re-submitting the NDA. In August 2011, it completed patient visits and analyzed top-line data from the first Phase 1 clinical trial of two RHI-based formulations. The trial was a single-center, randomized, double-blind, three-period crossover trial in 18 subjects with Type 1 diabetes. The purpose of the trial was to evaluate the pharmacokinetic and pharmacodynamic characteristics and injection site toleration of BIOD-105 and BIOD-107, as compared to the insulin analog marketed as Humalog. The Company conducted Phase I, Phase II and Phase III clinical trials comparing the performance of its Linjeta formulation of RHI to either Humulin, which is a branded formulation of RHI or Humalog. Its pivotal Phase III clinical trials were open-label, parallel group, randomized trials conducted at centers in the United States, Germany and India.
The Company competes with Eli Lilly, Novo Nordisk, Sanofi-Aventis, Halozyme Therapeutics, Inc. and MannKind Corporation.
Advisors' Opinion:- [By Roberto Pedone]
One under-$10 specialty biopharmaceutical player that's starting to trend within range of triggering a big breakout trade is Biodel (BIOD), which is focused on the development and commercialization of innovative treatments for diabetes. This stock has been hit hard by the bears over the last three months, with shares down by 24%.
If you take a look at the chart for Biodel, you'll notice that this stock is ripping higher here right off its 50-day moving average of $2.32 a share with strong upside volume. Volume on Thursday has so far registered over 750,000 shares, which is well above its three-month average action of 445,084 shares. This move is quickly pushing shares of BIOD within range of triggering a big breakout trade.
Traders should now look for long-biased trades in BIOD if it manages to break out above some near-term overhead resistance levels at $2.52 to $2.60 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 445,084 shares. If that breakout triggers soon, then BIOD will set up to re-test or possibly take out its next major overhead resistance levels $3 to its 200-day moving average of $3.39 a share. Any high-volume move above $3.39 will then give BIOD a chance to tag $4 a share.
Traders can look to buy BIOD off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $2.10 a share. One can also buy BIOD off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Best Tech Stocks To Own Right Now: ManpowerGroup(MAN)
ManpowerGroup provides workforce solutions and services worldwide. The company offers permanent, temporary, and contract recruitment services; assessment and selection services; training and development services; outsourcing services; and workforce consulting services. It also provides professional resourcing and project-based workforce solutions in the information technology, finance, and engineering fields; talent and career management workforce solutions; and talent based outsourcing services, managed services, recruitment process outsourcing services, borderless talent solutions, and strategic workforce consulting services. The company was founded in 1948 and is headquartered in Milwaukee, Wisconsin.
Advisors' Opinion:- [By Louis Navellier , NavellierGrowth.com]
So without further ado, here are five companies that have the analyst community buzzing, and they should be on your radar as well.
Best Buy (BBY): In the past two months, estimates have been revised up 22%. Analysts now expect 175% year-on-year earnings growth this quarter. Meanwhile, the industry average is 30% annual earnings growth. . ManpowerGroup (MAN): In the past month, the consensus estimate has been hiked up 19% to $1.08 per share. Analysts now expect 37% earnings growth. MAN is a buy. Netflix (NFLX): In the past three months, the consensus estimate has climbed 9%. Analysts now forecast 22% sales growth and a whopping 269% earnings growth. NFLX is a strong buy. Tesla (TSLA): In the past three months, analysts have completely reversed their projections. Earlier, the consensus was that Tesla Motors would post a net loss of 3 cents per share. Now the consensus calls for earnings of 12 cents per share. This translates into 113% earnings growth! TSLA is a strong buy. Whirlpool (WHR): In the past three months, earnings estimates have risen 15%. Analysts now expect 47% earnings growth. WHR is a strong buy.To put these earnings estimates into perspective, analysts forecast that the average S&P 500 company will grow earnings by 15.1% this quarter. This means that each of the five buys above are well-positioned to win big next earnings season, which kicks off on October 8. If you want to see how the analyst community feels about one of your holdings, feel free to run it through my Portfolio Grader screening tool. After hitting “submit,” you’ll see that one of the components of the stock’s Fundamental Grade is “Analyst Earnings Revisions.”
- [By Dan Burrows]
Staffing stocks like Manpower Group (MAN), Robert Half International (RHI) and Kelly Services (KELYA) have put up market-beating to market-crushing gains over the last year, boosted by accelerating strength in the job market.
Best Tech Stocks To Own Right Now: Cabot Microelectronics Corporation(CCMP)
Cabot Microelectronics Corporation engages in the development, manufacture, and sale of chemical mechanical planarization (CMP) consumables to the semiconductor industry primarily in the United States, Asia, and Europe. CMP is a polishing process used by integrated circuit (IC) device manufacturers to planarize or flatten the multiple layers of material that are deposited upon silicon wafers in the production of advanced ICs. The company offers CMP slurries, which are liquid solutions composed of high-purity deionized water, proprietary chemical additives, and engineered abrasives that chemically and mechanically interact with the surface material of the IC device at an atomic level; and CMP polishing pads that are engineered polymeric materials designed to distribute and transport the slurry to the surface of the wafer and distribute it evenly across the wafer. Its CMP slurries are used for various polishing applications, including materials that conduct electrical signal s, such as tungsten, copper, tantalum, and aluminum; the dielectric insulating materials that separate conductive layers within logic and memory IC devices; and the disk substrates and magnetic heads used in hard disk drives. The company also designs and produces precision polishing and metrology systems to attain shape and surface finish on various optical components, such as mirrors, lenses, and prisms. It serves producers of logic IC devices and memory IC devices, as well as IC foundries. The company was founded in 1999 and is headquartered in Aurora, Illinois.
Advisors' Opinion:- [By Whitney Kisling]
That alert proved too optimistic and the exchange pushed back the open another 15 minutes. By 3:25 p.m., Nasdaq stocks started ticking again. With the close about 35 minutes away, both the Nasdaq Composite Index (CCMP) and the Nasdaq 100 Index began to rise.
- [By Nikolaj Gammeltoft]
Not all of Granville�� best calls were in the distant past. On March 11, 2000, the day after the Nasdaq Composite Index (CCMP) jumped to a record 5048.62, Granville wrote that investors in technology stocks ��ill soon be burned.��The index, heavy on computer-related companies, tumbled about 78 percent before bottoming on Oct. 9, 2002.
No comments:
Post a Comment